181 related articles for article (PubMed ID: 23990192)
1. Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways.
Piotrowski R; Kryński T; Baran J; Futyma P; Stec S; Kułakowski P
Cardiol J; 2014; 21(3):299-303. PubMed ID: 23990192
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm.
Kose S; Amasyali B; Aytemir K; Can I; Kilic A; Kursaklioglu H; Iyisoy A; Isik E
Heart Vessels; 2005 Jul; 20(4):142-6. PubMed ID: 16025362
[TBL] [Abstract][Full Text] [Related]
3. Effect of Antazoline on Electrophysiological Properties of Atrial Muscle and Conduction System of the Heart.
Bińkowski BJ; Makowski M; Kubiński P; Lubiński A
Cardiovasc Drugs Ther; 2018 Apr; 32(2):169-173. PubMed ID: 29623481
[TBL] [Abstract][Full Text] [Related]
4. [High frequency catheter ablation of left-sided manifest accessory conduction pathways during sinus rhythm and in continuous atrial fibrillation].
Chen X; Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
Z Kardiol; 1994; 83 Suppl 5():121-5. PubMed ID: 7846941
[TBL] [Abstract][Full Text] [Related]
5. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.
Maia IG; Cruz Filho FE; Fagundes ML; Boghossian SH; Vanheusden L; Sa RM; Alves PA
J Am Coll Cardiol; 1995 Nov; 26(5):1310-4. PubMed ID: 7594048
[TBL] [Abstract][Full Text] [Related]
6. Dependency on atrial electrophysiological properties of appearance of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome: evidence from atrial vulnerability before and after radiofrequency catheter ablation and surgical cryoablation.
Muraoka Y; Karakawa S; Yamagata T; Matsuura H; Kajiyama G
Pacing Clin Electrophysiol; 1998 Feb; 21(2):438-46. PubMed ID: 9507546
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of antazoline in the rapid cardioversion of paroxysmal atrial fibrillation (the AnPAF Study).
Maciag A; Farkowski MM; Chwyczko T; Beckowski M; Syska P; Kowalik I; Pytkowski M; Wozniak J; Dabrowski R; Szwed H
Europace; 2017 Oct; 19(10):1637-1642. PubMed ID: 28339554
[TBL] [Abstract][Full Text] [Related]
8. Early repolarization in the inferior leads after accessory pathway ablation is highly correlated with atrial fibrillation in Wolff-Parkinson-White syndrome.
Chen M; Wang Q; Sun J; Zhang PP; Li W; Mo BF; Li YG
J Cardiol; 2020 Mar; 75(3):323-329. PubMed ID: 31445855
[TBL] [Abstract][Full Text] [Related]
9. Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).
Farkowski MM; Maciag A; Kowalik I; Konka M; Szwed H; Pytkowski M
Br J Clin Pharmacol; 2019 Jul; 85(7):1552-1558. PubMed ID: 30920001
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency catheter ablation at the non-coronary cusp for the treatment of para-hisian accessory pathways.
Xu G; Liu T; Liu E; Ye L; Shehata M; Wang X; Li G
Europace; 2015 Jun; 17(6):962-8. PubMed ID: 25355782
[TBL] [Abstract][Full Text] [Related]
11. Atrial vulnerability is a major mechanism of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
Zhang Y; Wang L
Med Hypotheses; 2006; 67(6):1345-7. PubMed ID: 16697118
[TBL] [Abstract][Full Text] [Related]
12. Increased P wave dispersion after the radiofrequency catheter ablation in overt pre-excitation patients: the role of atrial vulnerability.
Soylu M; Demir AD; Ozdemir O; Soylu O; Topaloğlu S; Korkmaz S; Saşmaz A
Int J Cardiol; 2004 Jun; 95(2-3):167-70. PubMed ID: 15193815
[TBL] [Abstract][Full Text] [Related]
13. Antazoline for termination of atrial fibrillation during the procedure of pulmonary veins isolation.
Balsam P; Koźluk E; Peller M; Piątkowska A; Lodziński P; Kiliszek M; Kołtowski Ł; Grabowski M; Opolski G
Adv Med Sci; 2015 Sep; 60(2):231-5. PubMed ID: 25919055
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of accessory pathways in patients with the Wolff-Parkinson-White syndrome: the long-term mortality and risk of atrial fibrillation.
Borregaard R; Lukac P; Gerdes C; Møller D; Mortensen PT; Pedersen L; Nielsen JC; Jensen HK
Europace; 2015 Jan; 17(1):117-22. PubMed ID: 25013013
[TBL] [Abstract][Full Text] [Related]
15. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
Duckeck W; Kuck KH
Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study.
Pappone C; Vicedomini G; Manguso F; Baldi M; Pappone A; Petretta A; Vitale R; Saviano M; Ciaccio C; Giannelli L; Calovic Z; Tavazzi L; Santinelli V
Circulation; 2012 Feb; 125(5):661-8. PubMed ID: 22215859
[TBL] [Abstract][Full Text] [Related]
17. Chronic atrial fibrillation is a biatrial arrhythmia: data from catheter ablation of chronic atrial fibrillation aiming arrhythmia termination using a sequential ablation approach.
Rostock T; Steven D; Hoffmann B; Servatius H; Drewitz I; Sydow K; Müllerleile K; Ventura R; Wegscheider K; Meinertz T; Willems S
Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):344-53. PubMed ID: 19808429
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
Hamada T; Hiraki T; Ikeda H; Kubara I; Yoshida T; Ohga M; Imaizumi T
J Cardiovasc Electrophysiol; 2002 Mar; 13(3):223-9. PubMed ID: 11942586
[TBL] [Abstract][Full Text] [Related]
19. Wolff-Parkinson-White syndrome in the era of catheter ablation: insights from a registry study of 2169 patients.
Pappone C; Vicedomini G; Manguso F; Saviano M; Baldi M; Pappone A; Ciaccio C; Giannelli L; Ionescu B; Petretta A; Vitale R; Cuko A; Calovic Z; Fundaliotis A; Moscatiello M; Tavazzi L; Santinelli V
Circulation; 2014 Sep; 130(10):811-9. PubMed ID: 25052405
[TBL] [Abstract][Full Text] [Related]
20. Double atrial potentials in left-sided accessory pathways are associated with paroxysmal atrial fibrillation.
Błaszyk K; Gwizdała A; Waśniewski M; Hiczkiewicz J; Seniuk W; Michalak M
J Cardiovasc Electrophysiol; 2018 Jan; 29(1):22-29. PubMed ID: 28940905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
